Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Dermata Therapeutics, Inc. - Common Stock (NQ:DRMA)

1.421 -0.509 (-26.37%)
Streaming Delayed Price Updated: 11:00 AM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dermata Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Dermata Completes Enrollment in First Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
Via ACCESSWIRE
News headline image
Life Sciences Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Via ACCESSWIRE
News headline image
Life Sciences Investor Forum Agenda Announced for November 14th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Peering Into Dermata Therapeutics's Recent Short Interest ↗
 
Via Benzinga
News headline image
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
Via ACCESSWIRE
News headline image
Why Is Dermata Therapeutics (DRMA) Stock Up 200% Today? ↗
Dermata Therapeutics stock is up on Wednesday with heavy trading of the company's shares despite a lack of news this morning. 
Via InvestorPlace
News headline image
Dermata Therapeutics to Present at the Life Sciences Investor Forum on Thursday, November 14, 2024
– Dermata Therapeutics invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com – 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Dermata Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit on Tuesday, October 15, 2024
Via ACCESSWIRE
News headline image
Dermata Therapeutics Announces Closing of $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Via ACCESSWIRE
News headline image
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Dermata Announces Achievement of 50% Enrollment in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
Via ACCESSWIRE
News headline image
Dermata Therapeutics Announces $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Via ACCESSWIRE
News headline image
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September ↗
 
Via Benzinga
Topics Stocks
News headline image
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Dermata Therapeutics Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024
Via ACCESSWIRE
News headline image
Texas Instruments To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
News headline image
7 F-Rated Growth Stocks to Avoid Like the Plague in August 2024 ↗
If your growth stocks have stopped growing then you may be holding on to F-rated growth stocks. It's time to sell. 
Via InvestorPlace
News headline image
DRMA Stock Earnings: Dermata Therapeutics Misses EPS for Q2 2024 ↗
DRMA stock results show that Dermata Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them! 
Via InvestorPlace
News headline image
Dermata Therapeutics Shares Are Trading Over 100%: What You Need To Know ↗
Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares are trading higher Wednesday. Here's what you need to know. 
Via Benzinga
News headline image
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Nasdaq Down 2%; Alphabet Posts Upbeat Earnings ↗
 
Via Benzinga
News headline image
Why Is Azitra (AZTR) Stock Down 75% Today? ↗
Azitra stock is falling on Wednesday as shares of AZTR come off of a massive rally yesterday alongside a new patent update. 
Via InvestorPlace
Topics Intellectual Property
News headline image
Why Is Nuzee (NUZE) Stock Up 133% Today? ↗
Nuzee stock is up on Wednesday with heavy trading of NUZE shares despite a lack of news from the coffee machine company. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news to start the day with! 
Via InvestorPlace
News headline image
Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.